RecruitingNot ApplicableNCT07182045

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.


Sponsor

The University of Texas Health Science Center, Houston

Enrollment

120 participants

Start Date

Sep 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria2

  • Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/>5cm or
  • Patients undergoing minimally invasive Myomectomy with =/> 5 fibroids

Exclusion Criteria4

  • Pregnancy,
  • Age <18yo,
  • Patients undergoing concomitant surgery such as endometriosis surgery,
  • Suspected malignancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTemporary clamping of uterine and ovarian vessels

Surgeon will temporarily clamp uterine and ovarian vessels.


Locations(1)

Memorial Hermann Hospital

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07182045


Related Trials